IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 311 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $975,191,101 | +10.7% | 21,498,922 | +0.2% | 0.08% | +13.5% |
| Q2 2023 | $880,660,371 | -42.5% | 21,463,816 | -49.9% | 0.07% | +5.7% |
| Q1 2023 | $1,532,269,154 | +90.4% | 42,872,668 | +101.2% | 0.07% | -12.5% |
| Q4 2022 | $804,784,993 | -14.5% | 21,307,519 | +0.1% | 0.08% | -18.4% |
| Q3 2022 | $941,708,000 | +19.6% | 21,291,159 | +0.1% | 0.10% | +25.6% |
| Q2 2022 | $787,399,000 | -0.3% | 21,269,560 | -0.2% | 0.08% | +23.8% |
| Q1 2022 | $789,725,000 | +22.5% | 21,320,886 | +0.7% | 0.06% | +31.2% |
| Q4 2021 | $644,553,000 | -9.2% | 21,181,502 | +0.0% | 0.05% | -14.3% |
| Q3 2021 | $710,114,000 | -15.8% | 21,172,154 | +0.1% | 0.06% | -15.2% |
| Q2 2021 | $843,452,000 | -11.1% | 21,144,455 | +0.2% | 0.07% | -18.5% |
| Q1 2021 | $948,382,000 | -19.9% | 21,093,896 | +0.7% | 0.08% | -22.9% |
| Q4 2020 | $1,183,836,000 | +19.6% | 20,938,034 | +0.3% | 0.10% | +5.0% |
| Q3 2020 | $990,137,000 | -19.3% | 20,866,952 | +0.3% | 0.10% | -25.9% |
| Q2 2020 | $1,226,990,000 | +23.8% | 20,810,554 | -0.7% | 0.14% | -1.5% |
| Q1 2020 | $990,999,000 | -21.7% | 20,960,227 | 0.0% | 0.14% | -2.1% |
| Q4 2019 | $1,266,207,000 | +1.0% | 20,960,227 | +0.1% | 0.14% | -6.7% |
| Q3 2019 | $1,254,263,000 | -6.7% | 20,935,784 | +0.1% | 0.15% | -4.5% |
| Q2 2019 | $1,343,839,000 | -19.8% | 20,909,262 | +1.3% | 0.16% | -21.9% |
| Q1 2019 | $1,674,837,000 | +51.1% | 20,633,698 | +0.6% | 0.20% | +32.2% |
| Q4 2018 | $1,108,757,000 | +5.0% | 20,509,750 | +0.2% | 0.15% | +27.7% |
| Q3 2018 | $1,055,525,000 | +34.5% | 20,463,839 | +8.7% | 0.12% | +32.2% |
| Q2 2018 | $784,565,000 | -5.4% | 18,828,057 | +0.1% | 0.09% | -8.2% |
| Q1 2018 | $829,166,000 | -11.9% | 18,810,482 | +0.5% | 0.10% | -10.9% |
| Q4 2017 | $941,582,000 | -0.4% | 18,719,325 | +0.4% | 0.11% | -3.5% |
| Q3 2017 | $945,717,000 | -0.0% | 18,653,203 | +0.3% | 0.11% | -3.4% |
| Q2 2017 | $945,919,000 | +26.8% | 18,594,834 | +0.2% | 0.12% | +24.2% |
| Q1 2017 | $746,210,000 | -14.2% | 18,562,420 | +2.1% | 0.10% | -18.1% |
| Q4 2016 | $869,570,000 | +30.8% | 18,180,445 | +0.2% | 0.12% | +30.3% |
| Q3 2016 | $664,571,000 | +57.5% | 18,137,854 | +0.1% | 0.09% | +53.4% |
| Q2 2016 | $421,955,000 | -41.4% | 18,117,448 | +1.8% | 0.06% | -42.0% |
| Q1 2016 | $720,580,000 | -34.3% | 17,792,097 | +0.5% | 0.10% | -32.4% |
| Q4 2015 | $1,096,840,000 | – | 17,710,957 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |